| BASF AG www.basf.com | | Industry Group Code: 325000 | | | | Ranks within this company's industry group: | | Sales: 1 | Profits:1 |
| | | Drugs: | | Discovery: | | | Licensing: | | | Manufacturing: | | | Generics: | | | | | | | |
| | Other: | | AgriBio: | | | Genomics: | | | Proteomics: | | | Tissue Replacement: | | | | | | | |
| | Clinical: | | Trials/Services: | | | Labs: | | | Equipment/Supplies: | Y | | Research/Dev. Svcs: | Y | | Diagnostics: | | | |
| | Computers: | | Hardware: | | | Software: | | | Arrays: | | | Database Management: | | | | | |
| | Specialty: | | Specialty Services: | | | Consulting: | | | Blood Collection: | | | Drug Delivery: | | | Drug Distribution: | | | | |
| |
| TYPES OF BUSINESS: | BRANDS/DIVISIONS/AFFILIATES | Chemicals Manufacturing
Agricultural Products
Oil & Gas Production
Plastics
Coatings
Nanotechnology Research
Nutritional Products
Agricultural Biotechnology
|
| Wintershall AG
BASF Canada
BASF Future Business GMBH
Sorex Holdings Ltd
Ciba Holding AG
BASF AG
| | CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. | Jurgen Hambrect, CEO
Kurt W. Bock, CFO
Harald Schwager, Exec. Dir.-Human Resources
Stefan Marcinowski, Exec. Dir.-Specialty Chemicals Research Div.
Kurt W. Bock, Exec. Dir.-Info. Svcs.
Magdalena Moll, Sr. VP-Investor Rel.
Kurt W. Bock, Exec. Dir.-Finance
Andreas Kreimeyer, Exec. Dir.-Inorganics & Petrochemicals
John Feldmann, Exec. Dir.-Construction & Performance Chemicals
Stefan Marcinowski, Exec. Dir.-Crop Protection
Juergen Hambrecht, Chmn.
Martin Brudermueller, Exec. Dir.-Asia Pacific Div.
Hans-Ulrich Engel, Exec. Dir.-Procurement & Logistics
| | Phone: 49-621-60-0 | | Fax: 49-621-60-42525 | | Toll-Free: N/A | Address: 38 Carl-Bosch St.,
Ludwigshafen 67056 Germany |
| | GROWTH PLANS/SPECIAL FEATURES | BASF SE, formerly BASF AG, is a chemical manufacturing company that serves customers in more than 170 countries. Around 19% of BASF sales are made to North American industries. The firm operates in six business segments: chemicals; plastics; performance products; agricultural solutions; functional solutions; and oil and gas. The chemicals segment manufactures inorganic, petrochemical and intermediate chemicals for the pharmaceutical, construction, textile and automotive industries. The plastics segment primarily manufactures polystyrene, styrenics and performance polymers for the manufacturing and packaging industries. The performance polymers segment produces pigments, inks, printing supplies, coatings and polymers for the automotive, oil, packaging, textile, detergent, sanitary care, construction and chemical industries. The firm's agricultural solutions segment produces and markets genetically engineered plants, nutritional supplements, herbicides, fungicides and insecticides for use in agriculture, public health and pest control. The functional solutions segment develops automotive and industrial catalysts; construction chemicals; and coatings and refinishes for automotive and construction markets. The oil and gas segment is operated through BASF subsidiary Wintershall AG, which focuses on petroleum and natural gas exploration and production in North America, Asia, Europe, the Middle East and Africa. BASF also employs chemical nanotechnology in pigments that are used to color coatings, paints and plastics; and sunscreen. The company is one of the world's leading R&D firms, with 8,000 employees working in research in 70 sites worldwide, employing a research budget of $1.3 billion Euros yearly. In April 2009, the firm acquired specialty chemicals maker Ciba Holding AG. Also in 2009, BASF announced plans to eliminate 2,000 jobs and shorten hours for another 3,000 workers. In June 2010, the company agreed to purchase Cognis Deutschland GmbH & Co KG, a specialty chemicals company, for approximately $ 4.1 billion.
U.S. employees are offered medical, dental and vision insurance; life insurance; disability coverage; an employee savings plan; tuition reimbursement; adoption assistance; and a supplier discount. |
| FINANCIALS: Sales and profits are in thousands of dollars-add 000 to get the full amount. Yr. 2009 note: Fiscal 2009 results were not available for all companies at press time. For this company, yr. 2009 is for months. | | 2009 Sales: | $67,557,500 | | 2009 Profits: | $1,879,080 | | | 2008 Sales: | $83,990,800 | | 2008 Profits: | $3,925,610 | | | 2007 Sales: | $78,122,600 | | 2007 Profits: | $5,479,950 | | | 2006 Sales: | $69,448,400 | | 2006 Profits: | $4,575,330 | | | 2005 Sales: | $52,080,500 | | 2005 Profits: | $3,663,700 | | Stock Ticker: BF | Employees: | Fiscal Year Ends: 12/31 |
| SALARIES/BENEFITS: | | Pension Plan: | ESOP Stock Plan: 96,924 | Profit Sharing: | | Savings Plan: | Stock Purch. Plan: | | | | | | Top Exec. Salary: Unavailable | Bonus: Unavailable | | Second Exec. Salary: Unavailable | Bonus: Unavailable |
| OTHER THOUGHTS: | LOCATIONS: ('Y' = YES) | | Apparent Top Female Officers: 2 | W | SW | MW | SE | NE | INTER. | | Hot Spots for Advancement for Women/Minorities: Y | Y | Y | Y | Y | Y | Y |
|